BIOASIS TECHNOLOGIES INC (BTI.CA) Stock News

Canada - TSX-V:BTI - CA09064N1033 - Common Stock

0.005 CAD

0 (0%)

Last: 3/18/2024, 7:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BTI.CA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Bioasis Technologies Inc.

Bioasis Provides Corporate Update and Announces Suspension of Operations

2 years ago - By: Bioasis Technologies Inc.

Bioasis Provides Corporate Update and Announces Suspension of Operations

3 years ago - By: Bioasis Technologies Inc.

Bioasis Provides Update on Business Operations

3 years ago - By: Bioasis Technologies Inc.

Bioasis Announces AGM Results and Provides Update on Financial Position

3 years ago - By: Bioasis Technologies Inc.

Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc

3 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022

3 years ago - By: Bioasis Technologies Inc.

Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders

3 years ago - By: Bioasis Technologies Inc.

Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc

3 years ago - By: Bioasis Technologies Inc.

Bioasis Technologies Inc. Announces Shareholder Webinar

3 years ago - By: Bioasis Technologies Inc.

Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc

3 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022

3 years ago - By: Bioasis Technologies Inc.

Bioasis Technologies Inc. Announces Stock Option Grants

3 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A

3 years ago - By: Bioasis Technologies Inc.

Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets

3 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A

3 years ago - By: Bioasis Technologies Inc.

Bioasis and Neuramedy Enter into Research Collaboration and License Agreement

4 years ago - By: Bioasis Technologies Inc.

Bioasis Enters Into Research Collaboration With Janssen

4 years ago - By: Bioasis Technologies Inc.

Bioasis to Attend and Present at Upcoming Industry Conference

4 years ago - By: Bioasis Technologies Inc.

Bioasis Announces $200,000 Non-Brokered Private Placement

4 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2021

4 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Annual General Meeting Results

4 years ago - By: Bioasis Technologies Inc.

Bioasis to Attend and Present at Upcoming Industry Conferences

4 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Annual General Meeting Details

4 years ago - By: Bioasis Technologies Inc.

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2021